Aliasger K. Salem - Phase I Clinical Trial of High Doses of Seleno-L-methionine in Combination with Axitinib in Patients with Previously Treated Metastatic Clear Cell Renal Cell Carcinoma

January 29, 2025

Alternate URL: https://doi.org/10.1158/1078-0432.CCR-24-3234

NSF Logo This material is based upon work supported by the National Science Foundation under Award No.2242763

Share this story